Trademarkia Logo

Canada

C$
Trademark Search in Canada
GRITSTONE

View On IC.GC.CA

GRITSTONE
REGISTERED

on 22 Jun 2021

Last Applicant/ Owned by

GRITSTONE ONCOLOGY INC.

5858 Horton Street, Suite 210Emeryville, CA 94608

US

Serial Number

1908106 filed on 6th Jul 2018

Registration Number

TMA1102479 registered on 22nd Jun 2021

Registration expiry Date

22nd Jun 2031

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

800 rue du Square Victoria, bureau 3500Montréal,

QUEBEC

CA

H4Z1E9

GRITSTONE

Trademark usage description

pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; human vaccines; human vaccine preparations next-generation sequenc Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; human vaccines; human vaccine preparations

Classification kind code

11

Class [009]
Next-generation sequencing (NGS) data processor; bioinformatics data processor; downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry

Classification kind code

11

Class [042]
Providing temporary use of online non-downloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals for others; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, artificial intelligence based cancer immunotherapy software platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services for others in the field of design, planning, and implementation of clinical trials; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice

Classification kind code

11

Class [044]
Health care services for detecting and treating cancer

Classification kind code

11

Mark Details

Serial Number

1908106

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 17th Feb 2021		Registration Pending
Submitted for opposition 191
on 17th Feb 2021		Registration Fee Notice Sent
Submitted for opposition 42
on 25th Nov 2020		Advertised
Submitted for opposition 26
on 29th Oct 2020		Approved
Submitted for opposition 27
on 29th Oct 2020		Approval Notice Sent
Submitted for opposition 22
on 17th Jun 2020		Search Recorded
Submitted for opposition 20
on 17th Jun 2020		Examiner's First Report
Submitted for opposition 31
on 11th Jul 2018		Formalized
Submitted for opposition 1
on 9th Jul 2018		Created
Submitted for opposition 30
on 6th Jul 2018		Filed